Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 40 of 40 entries
Sorted by: Best Match Show Resources per page
Deficiencies in immunoassay methods used to monitor serum Estradiol levels during aromatase inhibitor treatment in postmenopausal breast cancer patients.

SpringerPlus

Jaque J, Macdonald H, Brueggmann D, Patel SK, Azen C, Clarke N, Stanczyk FZ.
PMID: 23520572
Springerplus. 2013 Dec;2(1):5. doi: 10.1186/2193-1801-2-5. Epub 2013 Jan 11.

Optimal care for breast cancer patients undergoing aromatase inhibitor (AI) treatment is ensured when estradiol (E2) levels are adequately suppressed. To assess treatment efficacy accurately, it is important to measure the serum E2 levels using a well validated assay...

Cite
Jaque J, Macdonald H, Brueggmann D, et al. Deficiencies in immunoassay methods used to monitor serum Estradiol levels during aromatase inhibitor treatment in postmenopausal breast cancer patients. Springerplus. 2013;2(1):5doi: 10.1186/2193-1801-2-5.
Jaque, J., Macdonald, H., Brueggmann, D., Patel, S. K., Azen, C., Clarke, N., & Stanczyk, F. Z. (2013). Deficiencies in immunoassay methods used to monitor serum Estradiol levels during aromatase inhibitor treatment in postmenopausal breast cancer patients. SpringerPlus, 2(1), 5. https://doi.org/10.1186/2193-1801-2-5
Jaque, Jenny, et al. "Deficiencies in immunoassay methods used to monitor serum Estradiol levels during aromatase inhibitor treatment in postmenopausal breast cancer patients." SpringerPlus vol. 2,1 (2013): 5. doi: https://doi.org/10.1186/2193-1801-2-5
Jaque J, Macdonald H, Brueggmann D, Patel SK, Azen C, Clarke N, Stanczyk FZ. Deficiencies in immunoassay methods used to monitor serum Estradiol levels during aromatase inhibitor treatment in postmenopausal breast cancer patients. Springerplus. 2013 Dec;2(1):5. doi: 10.1186/2193-1801-2-5. Epub 2013 Jan 11. PMID: 23520572; PMCID: PMC3599208.
Copy Download .nbib Format: NLM
Nitride superluminescent diodes with broadened emission spectrum fabricated using laterally patterned substrate.

Optics express

Kafar A, Stanczyk S, Sarzynski M, Grzanka S, Goss J, Targowski G, Nowakowska-Siwinska A, Suski T, Perlin P.
PMID: 27137581
Opt Express. 2016 May 02;24(9):9673-82. doi: 10.1364/OE.24.009673.

We demonstrate InGaN/GaN superluminescent diodes with broadened emission spectra fabricated on surface-shaped bulk GaN (0001) substrates. The patterning changes the local vicinal angle linearly along the device waveguide, which results in an indium incorporation profile in InGaN quantum wells....

Cite
Kafar A, Stanczyk S, Sarzynski M, et al. Nitride superluminescent diodes with broadened emission spectrum fabricated using laterally patterned substrate. Opt Express. 2016;24(9):9673-82doi: 10.1364/OE.24.009673.
Kafar, A., Stanczyk, S., Sarzynski, M., Grzanka, S., Goss, J., Targowski, G., Nowakowska-Siwinska, A., Suski, T., & Perlin, P. (2016). Nitride superluminescent diodes with broadened emission spectrum fabricated using laterally patterned substrate. Optics express, 24(9), 9673-82. https://doi.org/10.1364/OE.24.009673
Kafar, A, et al. "Nitride superluminescent diodes with broadened emission spectrum fabricated using laterally patterned substrate." Optics express vol. 24,9 (2016): 9673-82. doi: https://doi.org/10.1364/OE.24.009673
Kafar A, Stanczyk S, Sarzynski M, Grzanka S, Goss J, Targowski G, Nowakowska-Siwinska A, Suski T, Perlin P. Nitride superluminescent diodes with broadened emission spectrum fabricated using laterally patterned substrate. Opt Express. 2016 May 02;24(9):9673-82. doi: 10.1364/OE.24.009673. PMID: 27137581.
Copy Download .nbib Format: NLM
Star-Shaped and Linear POSS-Polylactide Hybrid Copolymers.

Materials (Basel, Switzerland)

Rozga-Wijas K, Stanczyk WA, Kurjata J, Kazmierski S.
PMID: 28793447
Materials (Basel). 2015 Jul 17;8(7):4400-4420. doi: 10.3390/ma8074400.

Novel octakis-2[(6-hydroxyhexyl)thio]ethyl-octasilsesquioxane (POSS-S-OH) as well as heptaisobutyl-2[(6-hydroxyhexyl)thio]ethyl-octasilsesquioxane (iBu-POSS-S-OH) were synthesized. POSS structures, bearing both types of groups

Cite
Rozga-Wijas K, Stanczyk WA, Kurjata J, et al. Star-Shaped and Linear POSS-Polylactide Hybrid Copolymers. Materials (Basel). 2015;8(7):4400-4420doi: 10.3390/ma8074400.
Rozga-Wijas, K., Stanczyk, W. A., Kurjata, J., & Kazmierski, S. (2015). Star-Shaped and Linear POSS-Polylactide Hybrid Copolymers. Materials (Basel, Switzerland), 8(7), 4400-4420. https://doi.org/10.3390/ma8074400
Rozga-Wijas, Krystyna, et al. "Star-Shaped and Linear POSS-Polylactide Hybrid Copolymers." Materials (Basel, Switzerland) vol. 8,7 (2015): 4400-4420. doi: https://doi.org/10.3390/ma8074400
Rozga-Wijas K, Stanczyk WA, Kurjata J, Kazmierski S. Star-Shaped and Linear POSS-Polylactide Hybrid Copolymers. Materials (Basel). 2015 Jul 17;8(7):4400-4420. doi: 10.3390/ma8074400. PMID: 28793447; PMCID: PMC5455638.
Copy Download .nbib Format: NLM
Does timing matter when initiating elagolix in a natural menstrual cycle?.

F&S reports

Danis RB, Sriprasert I, Stanczyk FZ, Paulson RJ, Winer SA, Ho JR.
PMID: 34553156
F S Rep. 2021 May 31;2(3):308-313. doi: 10.1016/j.xfre.2021.05.009. eCollection 2021 Sep.

OBJECTIVE: To investigate the efficacy of elagolix when administered at different time points in a menstrual cycle.DESIGN: Clinical case series.SETTING: Academic reproductive endocrinology center.PATIENTS: Ovulatory women not desiring pregnancy.INTERVENTIONS: Six doses of elagolix 200 mg were administered over 4...

Cite
Danis RB, Sriprasert I, Stanczyk FZ, et al. Does timing matter when initiating elagolix in a natural menstrual cycle?. F S Rep. 2021;2(3):308-313doi: 10.1016/j.xfre.2021.05.009.
Danis, R. B., Sriprasert, I., Stanczyk, F. Z., Paulson, R. J., Winer, S. A., & Ho, J. R. (2021). Does timing matter when initiating elagolix in a natural menstrual cycle?. F&S reports, 2(3), 308-313. https://doi.org/10.1016/j.xfre.2021.05.009
Danis, Rachel B, et al. "Does timing matter when initiating elagolix in a natural menstrual cycle?." F&S reports vol. 2,3 (2021): 308-313. doi: https://doi.org/10.1016/j.xfre.2021.05.009
Danis RB, Sriprasert I, Stanczyk FZ, Paulson RJ, Winer SA, Ho JR. Does timing matter when initiating elagolix in a natural menstrual cycle?. F S Rep. 2021 May 31;2(3):308-313. doi: 10.1016/j.xfre.2021.05.009. eCollection 2021 Sep. PMID: 34553156; PMCID: PMC8441568.
Copy Download .nbib Format: NLM
Showing 37 to 40 of 40 entries